The following editorial is a response to the European Commission’s ‘Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions: Toward a comprehensive European Union framework on endocrine disruptors.’
Herman Autrup, Frank A. Barile, Sir Colin Berry, Bas J. Blaauboer, Alan Boobis, Herrmann Bolt, Christopher J. Borgert, Wolfgang Dekant, Daniel Dietrich, Jose L. Domingo, Gio Batta Gori, Helmut Greim, Jan Hengstler, Sam Kacew, Hans Marquardt, Olavi Pelkonen, Kai Savolainen, Pat Heslop-Harrison & Nico P. Vermeulen (2020) Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?, Journal of Toxicology and Environmental Health, Part A, 83:13-14, 485-494, DOI: 10.1080/15287394.2020.1756592
This editorial is being simultaneously published across the following nine toxicology journals: Journal of Toxicology and Environmental Health, Part A: Current Issues; Archives of Toxicology; Chemico-Biological Interactions; Computational Toxicology; Environmental Toxicology and Pharmacology; Food and Chemical Toxicology; Human and Experimental Toxicology; Toxicology in Vitro; and Toxicology Letters. This note serves to clarify the locations of this editorial.